Stocks
Insmed IncorporatedINSM
NASDAQHealthcareBiotechnology$139.50-0.01%
Price as of · delayed, not real-time
Focused on rare diseases, this biopharmaceutical company develops therapies for unmet medical needs, with its lead product targeting pulmonary conditions. Investors monitor Insmed for its pipeline progress and commercialization potential in niche markets.
Market Cap: $30.1B52W Range: $60.40 – $212.75
Congressional Interest in Insmed Incorporated (INSM)
3 members of Congress have disclosed 10 trades in Insmed Incorporated (INSM), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
10
Unique Politicians
3
Buys
3
Sells
7
Who in Congress Is Trading INSM?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-10-03 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-09-22 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-08-08 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-07-07 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-06-16 | Josh Gottheimer | buy | $1K – $15K |
| 2025-04-09 | Josh Gottheimer | sell | $1K – $15K |
| 2024-06-21 | Josh Gottheimer | sell | $1K – $15K |
| 2024-05-28 | Josh Gottheimer | sell | $1K – $15K |
| 2022-12-06 | Josh Gottheimer | buy | $1K – $15K |
| 2020-03-30 | Kurt Schrader | buy | $1K – $15K |